Shuaihu Li
3PUBLICATIONS
12CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (3)
Sort by Publication Date:
|Aug 27, 2025
An Optimized Platform Overcomes Excessive Tumor Immune Rejection Induced by the CRISPR/Cas9 Lentiviral System.Yan Shang, Shuaihu Li, Tian Xu
|Jun 19, 2024
Topical JAK inhibition ameliorates EGFR inhibitor-induced rash in rodents and humans.Qing You, Leying Chen, Shuaihu Li
|Mar 24, 2022
Remodeling of dermal adipose tissue alleviates cutaneous toxicity induced by anti-EGFR therapy.Leying Chen, Qing You, Min Liu
Pageof 1
